Related Experiment Video
Updated: Jan 7, 2026
10:37
Transcranial Direct Current Stimulation tDCS for Memory Enhancement
Published on: September 18, 2021
15.4K
Dementia Care Research and Psychosocial Factors
Charlotte Horowitz1, Eugene Pahk2
1Western University of Health Sciences, Pomona, CA, USA.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|December 25, 2025
Summary
A rare family with three siblings homozygous for the apolipoprotein E4 (APOE4) gene shows lifestyle changes may delay Alzheimer's disease onset. One sibling adopted a vegan diet and exercise regimen, experiencing slower cognitive decline compared to her affected sisters.
Area of Science:
- Genetics
- Neuroscience
- Gerontology
Background:
- Genetic factors significantly influence Alzheimer's Disease (AD) development.
- The apolipoprotein E4 (APOE4) gene is the strongest genetic risk factor for AD, especially in homozygous individuals.
- APOE4's role in lipid metabolism contributes to AD pathology, including amyloid-beta plaque and neurofibrillary tangle formation.
Purpose of the Study:
- To present a case study of a family with a high prevalence of APOE4 homozygosity and early-onset Alzheimer's disease.
- To explore the potential impact of significant lifestyle modifications on delaying AD progression in a genetically high-risk individual.
- To investigate the interplay between genetic predisposition (APOE4 homozygosity) and environmental factors in Alzheimer's disease.
Main Methods:
- Case study of a 69-year-old female presenting with memory loss and confirmed APOE4 homozygosity.
- Comparison of her clinical trajectory with two older siblings who developed early-onset Alzheimer's disease and share the same genetic profile.
- Detailed documentation of the patient's adoption of a vegan diet, regular exercise, improved sleep hygiene, and stress reduction strategies.
Main Results:
- The patient, homozygous for APOE4, has exhibited a significantly slower rate of cognitive symptom progression compared to her siblings.
- She has not yet received an official Alzheimer's disease diagnosis, despite her genetic risk and family history.
- This suggests a potential protective effect of the implemented lifestyle interventions.
Conclusions:
- The co-occurrence of APOE4 homozygosity and early-onset AD in three siblings is a rare genetic finding.
- This case highlights the potential for lifestyle interventions to modify the clinical course of Alzheimer's disease in genetically susceptible individuals.
- Further research, including biomarker analysis, is warranted to understand the mechanisms behind these protective effects and their implications for AD prevention.
More Related Videos
08:36The Immersive Cleveland Clinic Virtual Reality Shopping Platform for the Assessment of Instrumental Activities of Daily Living
Published on: July 28, 2022
4.3K
10:13Assessment of Age-related Changes in Cognitive Functions Using EmoCogMeter, a Novel Tablet-computer Based Approach
Published on: February 14, 2014
14.1K
Related Concept Videos
01:30Dementia
482
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
482
01:29Psychological and Sociocultural Causes of Schizophrenia
438
Schizophrenia, a complex psychiatric disorder, has been historically misunderstood. Early psychological theories attributed its origins to childhood trauma and unresponsive parenting. However, contemporary research largely rejects these notions, favoring the vulnerability-stress hypothesis. This model proposes that individuals with a genetic predisposition to schizophrenia may develop the disorder following exposure to significant environmental stressors. Notably, studies on high-risk...
438
01:26Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K
01:22Alzheimer's Disease: Treatment
744
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
744
01:30Cognitive Development During Adulthood
740
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
740
01:29Documentation in Long-Term and Home Healthcare Setting
1.4K
Documentation in long-term care facilities and home healthcare settings is crucial for ensuring continuous, coordinated, and comprehensive care for patients. Each setting has its specific documentation processes and tools:
Long-Term Care Facilities
Long-Term Care Facilities
1.4K